GENEVA, Dec. 24 -- WALDEN BIOSCIENCES, INC. (One Kendall Square, Suite 7101Cambridge, MA 02139) filed a patent application (PCT/US2025/033082) for "METHOD OF ADMINISTERING AN ANTI-SOLUBLE UROKINASE PLASOMINOGEN ACTIVATOR RECEPTOR ANTIBODY FOR THE TREATMENT OF KIDNEY DISEASE" on Jun 10, 2025. With publication no. WO/2025/259719, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DUNCAN, Alexander R. (Boston, Massachusetts, USc/o Walden Biosciences, Inc.One Kendall Square, Suite 7101Cambridge, MA 02139), MILLER, Thomas (Wakefi...